Barely Significant
← all excerpts

Real-world effectiveness of burosumab vs oral phosphate and active vitamin D in adults with X-linked hypophosphatemia.

J Bone Miner Res · 2025 · PMC12308825 · PMID 40314226

Europe PMCDOI
1
hedged sentence
0.0980
closest p · 2.0× alpha
0.0980
boldest claim

The sentences

did not reach statistical significancep = .098so close (0.05 < p ≤ 0.1)
The proportion of patients achieving the MCID for WOMAC stiffness was greater for the burosumab cohort vs the Pi/D cohort, but did not reach statistical significance (53.1% vs 32.9%; p = .098).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.